Zai Lab/$ZLAB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zai Lab
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Ticker
$ZLAB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
1,869
ISIN
US98887Q1040
Website
Zai Lab Metrics
BasicAdvanced
$3.4B
-
-$2.48
1.04
-
Price and volume
Market cap
$3.4B
Beta
1.04
52-week high
$39.77
52-week low
$16.01
Average daily volume
965K
Financial strength
Current ratio
3.258
Quick ratio
2.642
Long term debt to equity
1.519
Total debt to equity
23.718
Interest coverage (TTM)
-80.56%
Management effectiveness
Return on assets (TTM)
-15.50%
Return on equity (TTM)
-32.05%
Valuation
Price to revenue (TTM)
7.607
Price to book
4.19
Price to tangible book (TTM)
4.52
Price to free cash flow (TTM)
-13.324
Growth
Revenue change (TTM)
43.72%
Earnings per share change (TTM)
-29.08%
3-year revenue growth (CAGR)
34.76%
3-year earnings per share growth (CAGR)
-24.85%
What the Analysts think about Zai Lab
Analyst ratings (Buy, Hold, Sell) for Zai Lab stock.
Zai Lab Financial Performance
Revenues and expenses
Zai Lab Earnings Performance
Company profitability
Zai Lab News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zai Lab stock?
Zai Lab (ZLAB) has a market cap of $3.4B as of May 30, 2025.
What is the P/E ratio for Zai Lab stock?
The price to earnings (P/E) ratio for Zai Lab (ZLAB) stock is 0 as of May 30, 2025.
Does Zai Lab stock pay dividends?
No, Zai Lab (ZLAB) stock does not pay dividends to its shareholders as of May 30, 2025.
When is the next Zai Lab dividend payment date?
Zai Lab (ZLAB) stock does not pay dividends to its shareholders.
What is the beta indicator for Zai Lab?
Zai Lab (ZLAB) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.